SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011299
Filing Date
2021-05-13
Accepted
2021-05-13 16:21:57
Documents
77
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10q.htm   iXBRL 10-Q 1339561
2 ex10-2.htm EX-10.2 54082
3 ex31-1.htm EX-31.1 17229
4 ex32-1.htm EX-32.1 7221
  Complete submission text file 0001493152-21-011299.txt   7086138

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE lineagecellcom-20210331.xsd EX-101.SCH 65201
6 XBRL CALCULATION FILE lineagecellcom-20210331_cal.xml EX-101.CAL 68246
7 XBRL DEFINITION FILE lineagecellcom-20210331_def.xml EX-101.DEF 284232
8 XBRL LABEL FILE lineagecellcom-20210331_lab.xml EX-101.LAB 481087
9 XBRL PRESENTATION FILE lineagecellcom-20210331_pre.xml EX-101.PRE 383117
10 EXTRACTED XBRL INSTANCE DOCUMENT form10q_htm.xml XML 1034194
Mailing Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008
Business Address 2173 SALK AVENUE SUITE 200 CARLSBAD CA 92008 5105213390
Lineage Cell Therapeutics, Inc. (Filer) CIK: 0000876343 (see all company filings)

IRS No.: 943127919 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12830 | Film No.: 21919973
SIC: 2836 Biological Products, (No Diagnostic Substances)